# ATG16L1 promotes cell migration and invasion in high glucose–induced retinal capillary endothelial cells

**Authors:** Xinxiao Gao, Pinxue Xie, Wen Feng, Jindong Han, Xiaobo Tan

PMC · DOI: 10.3389/fmed.2025.1515936 · 2025-07-15

## TL;DR

This study shows that ATG16L1 promotes cell migration and invasion in retinal cells under high glucose conditions, which may contribute to diabetic retinopathy.

## Contribution

The study identifies ATG16L1 as a novel factor promoting retinal capillary endothelial cell migration in diabetic retinopathy.

## Key findings

- ATG16L1 expression is significantly upregulated in retinal cells under high glucose conditions.
- Knocking down ATG16L1 reduces cell migration and invasion in high glucose–treated retinal cells.
- ATG16L1 may play a role in the progression of diabetic retinopathy.

## Abstract

Diabetic retinopathy (DR), a common chronic complication of diabetes, often results in irreversible visual dysfunction. This study investigated the mechanisms underlying the expression of ATG16L1, a potential biomarker of DR.

We investigated the role of ATG16L1 in high glucose (HG)–induced retinal capillary endothelial cells (RCECs). Rat RCECs were cultured in normal glucose (NG) or HG medium with or without ATG16L1 transfection.

The mRNA and protein expression levels of ATG16L1 were significantly upregulated in RCECs exposed to HG medium. The migration ability and invasion rate of RCECs were significantly higher in the HG group than in the NG group but decreased markedly after transfection with ATG16L1 siRNA, compared with those in the control group (p < 0.01).

ATG16L1 might be involved in the development of DR by promoting the migration of RCECs.

## Linked entities

- **Genes:** ATG16L1 (autophagy related 16 like 1) [NCBI Gene 55054]
- **Diseases:** diabetic retinopathy (MONDO:0005266), diabetes (MONDO:0005015)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** MAP1LC3B (microtubule associated protein 1 light chain 3 beta) [NCBI Gene 81631] {aka ATG8F, LC3B, MAP1A/1BLC3, MAP1LC3B-a}, BECN1 (beclin 1) [NCBI Gene 8678] {aka ATG6, VPS30, beclin1}, GABARAPL2 (GABA type A receptor associated protein like 2) [NCBI Gene 11345] {aka ATG8, ATG8C, GATE-16, GATE16, GEF-2, GEF2}, NUP62 (nucleoporin 62) [NCBI Gene 23636] {aka IBSN, SNDI, p62}, ATG16L1 (autophagy related 16 like 1) [NCBI Gene 55054] {aka APG16L, ATG16A, ATG16L, IBD10, WDR30}, ATG12 (autophagy related 12) [NCBI Gene 9140] {aka APG12, APG12L, FBR93, HAPG12}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, ATG3 (autophagy related 3) [NCBI Gene 64422] {aka APG3, APG3-LIKE, APG3L, PC3-96, hApg3}, Atg16l1 (autophagy related 16-like 1) [NCBI Gene 363278] {aka Apg16l, Wdr30}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}, ATG4C (autophagy related 4C cysteine peptidase) [NCBI Gene 84938] {aka APG4-C, APG4C, AUTL1, AUTL3, HsAPG4C}, ATG5 (autophagy related 5) [NCBI Gene 9474] {aka APG5, APG5-LIKE, APG5L, ASP, SCAR25, hAPG5}
- **Diseases:** inflammation (MESH:D007249), PDR (OMIM:603933), diabetic optic neuropathy (MESH:D003929), peripheral nerve damage (MESH:D010523), hyperglycemia (MESH:D006943), vitreous hemorrhage (MESH:D014823), blindness (MESH:D001766), neurodegeneration (MESH:D019636), DR (MESH:D003930), diabetes (MESH:D003920), loss of vision (MESH:D014786), hypoxia (MESH:D000860), microangiopathy (MESH:D014652), retinal detachment (MESH:D012163), RCECs (MESH:D012164)
- **Chemicals:** advanced glycation end products (MESH:D017127), bicinchoninic acid (MESH:C047117), CO2 (MESH:D002245), streptomycin sulfate (MESH:D013307), polyacrylamide (MESH:C016679), ROS (MESH:D017382), sodium dodecyl sulfate (MESH:D012967), heparin sodium (MESH:D006493), paraformaldehyde (MESH:C003043), 3-MA (-), crystal violet (MESH:D005840), glucose (MESH:D005947), Tween 20 (MESH:D011136), TRIzol (MESH:C411644), hexosamine (MESH:D006595), penicillin sodium (MESH:D010400), polyvinylidene fluoride (MESH:C024865), polyol (MESH:C024617)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** RF/6A — Macaca mulatta (Rhesus macaque), Spontaneously immortalized cell line (CVCL_4552), ARPE-19 — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_0145), RPE — Homo sapiens (Human), Telomerase immortalized cell line (CVCL_4388)

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12303877/full.md

---
Source: https://tomesphere.com/paper/PMC12303877